590 related articles for article (PubMed ID: 9030745)
1. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes.
Blommaart EF; Krause U; Schellens JP; Vreeling-Sindelárová H; Meijer AJ
Eur J Biochem; 1997 Jan; 243(1-2):240-6. PubMed ID: 9030745
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes.
Dubbelhuis PF; Van Sluijters DA; Blommaart EF; Gustafson LA; Van Woerkom GM; Herling AW; Burger HJ; Meijer AJ
Biochem J; 2002 Dec; 368(Pt 3):827-33. PubMed ID: 12371905
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction.
Yano H; Agatsuma T; Nakanishi S; Saitoh Y; Fukui Y; Nonomura Y; Matsuda Y
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):145-50. PubMed ID: 7492304
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase.
Thomas JE; Venugopalan M; Galvin R; Wang Y; Bokoch GM; Vlahos CJ
J Cell Biochem; 1997 Feb; 64(2):182-95. PubMed ID: 9027579
[TBL] [Abstract][Full Text] [Related]
5. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of autophagy in mitotic animal cells.
Eskelinen EL; Prescott AR; Cooper J; Brachmann SM; Wang L; Tang X; Backer JM; Lucocq JM
Traffic; 2002 Dec; 3(12):878-93. PubMed ID: 12453151
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic protein degradation.
Blommaart EF; Luiken JJ; Meijer AJ
Contrib Nephrol; 1997; 121():101-8. PubMed ID: 9336704
[No Abstract] [Full Text] [Related]
9. Phosphatidylinositol 3'-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and downregulates cell-surface transferrin receptor numbers independently of any effect on fluid-phase endocytosis in fibroblasts.
Jess TJ; Belham CM; Thomson FJ; Scott PH; Plevin RJ; Gould GW
Cell Signal; 1996 Jun; 8(4):297-304. PubMed ID: 8842531
[TBL] [Abstract][Full Text] [Related]
10. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms.
Somwar R; Sumitani S; Taha C; Sweeney G; Klip A
Am J Physiol; 1998 Oct; 275(4):E618-25. PubMed ID: 9755080
[TBL] [Abstract][Full Text] [Related]
11. Effect of wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) on N-formyl-methionyl-leucyl-phenylalanine-induced phospholipase D activation in differentiated HL60 cells: possible involvement of phosphatidylinositol 3-kinase in phospholipase D activation.
Nakamura M; Nakashima S; Katagiri Y; Nozawa Y
Biochem Pharmacol; 1997 Jun; 53(12):1929-36. PubMed ID: 9256168
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine.
Crawley JB; Williams LM; Mander T; Brennan FM; Foxwell BM
J Biol Chem; 1996 Jul; 271(27):16357-62. PubMed ID: 8663063
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines.
Scheid MP; Duronio V
J Biol Chem; 1996 Jul; 271(30):18134-9. PubMed ID: 8663437
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways.
Párrizas M; Saltiel AR; LeRoith D
J Biol Chem; 1997 Jan; 272(1):154-61. PubMed ID: 8995241
[TBL] [Abstract][Full Text] [Related]
15. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils.
Ding J; Vlahos CJ; Liu R; Brown RF; Badwey JA
J Biol Chem; 1995 May; 270(19):11684-91. PubMed ID: 7744808
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of p70 S6 kinase activation by phosphatidylinositol 3-kinase inhibitors.
Petritsch C; Woscholski R; Edelmann HM; Parker PJ; Ballou LM
Eur J Biochem; 1995 Jun; 230(2):431-8. PubMed ID: 7607212
[TBL] [Abstract][Full Text] [Related]
17. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002).
Guo M; Joiakim A; Reiners JJ
Biochem Pharmacol; 2000 Sep; 60(5):635-42. PubMed ID: 10927021
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I.
Dardevet D; Sornet C; Vary T; Grizard J
Endocrinology; 1996 Oct; 137(10):4087-94. PubMed ID: 8828461
[TBL] [Abstract][Full Text] [Related]
19. Involvement of both phosphatidylinositol 3-kinase and p44/p42 mitogen-activated protein kinase pathways in the short-term regulation of pyruvate kinase L by insulin.
Carrillo JJ; Ibares B; Esteban-Gamboa A; Felíu JE
Endocrinology; 2001 Mar; 142(3):1057-64. PubMed ID: 11181519
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
